Androgen deprivation therapy and risk for COVID-19

Susceptibility to SARS-Cov-2 Infection and Risk for Severe COVID-19 in Patients with Prostate Cancer on Androgen Deprivation Therapy 

Artikel publicerad 8 juli 2022 baserat på datauttag från SIR.

Rolf Gedeborg1*, Stacy Loeb2, Johan Styrke3, Ritva Kiiski-Berggren4, Hans Garmo1,5, Pär Stattin1

https://doi.org/10.1002/ijc.34204